Drug intelligence / Profile preview

Hezandra

Development stage: Unknown
Lead developer: Combiphar
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Hezandra is an oral herbal supplement developed by Combiphar to support and maintain liver health. It is formulated with "Hepatoshield 7", a synergistic combination of seven active ingredients: *Curcuma longa* (turmeric/nanocurcuminoid), silymarin phytosome (milk thistle extract), *Schisandra chinensis* fruit extract, licorice (*Succus liquiritiae*) extract, choline bitartrate, vitamin B6, and vitamin E. The supplement provides hepatoprotective benefits, helping to reduce inflammation and protect liver function. It is approved in Indonesia as an over-the-counter (OTC) herbal supplement.

Brand names: Hezandra
Other names: Hepatoshield 7Hepatoshield7Hepatoshield-7Hezandra CapHezandra KapletHezandra Kapsul

Beyond the preview

Go deeper on Hezandra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hezandra.